Blood Biomarker May Detect Acute Heart Transplant Rejection
WEDNESDAY, Jan. 27, 2021 -- A blood biomarker, percent donor-derived cell-free DNA (%ddcfDNA), is promising for the early detection of acute rejection (AR) after heart transplant, according to a study published online Jan. 13 in Circulation.
Sean...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cardiology | Heart | Heart Transplant | Pharmaceuticals | Study | Transplant Surgery | Transplants